作为病毒感染中可能的治疗点的EPHA2受体
Marian Vincenzi1, Flavia Anna Mercurio1, Marilisa Leone1
1Institute of Biostructures and Bioimaging, National Research Council of Italy (CNR-IBB), Naples, Italy.
Current medicinal chemistry
|October 13, 2023
概括
埃法2受体氨酸激酶与病毒感染有关,作为KSHV和EBV等病毒的宿主受体. 针对EphA2可能提供新的抗病毒药物发现策略.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 受体氨酸激酶EphA2与各种疾病有关,包括癌症和骨质疏松症.
- 此外,EphA2也与病毒感染的发病有关.
研究的目的:
- 审查关于病毒感染中EphA2功能的当前文献.
- 探索EphA2作为抗病毒药物发现的潜在目标.
主要方法:
- 在PubMed和网络的文献中搜索链接EphA2与病毒的文章.
- 从蛋白质数据库 (PDB) 中检索EphA2-病毒蛋白质复杂结构.
主要成果:
- 在卡波西的肉瘤相关性疹病毒 (KSHV) 和爱斯坦巴尔病毒 (EBV) 感染中,EphA2直接与病毒糖蛋白结合.
- 埃法2可能会维持人类细胞巨核病毒 (HCMV) 延迟,并导致SARS-CoV-2感染的严重症状.
- 高Epha2表达可以加剧病毒感染症状,如肺损伤.
结论:
- EphA2 作为某些病毒的宿主受体,表明潜在的抗病毒疗法针对其连接体结合域.
- 需要进一步的研究来确认EphA2在SARS-CoV-2感染和炎症中的作用.
相关概念视频
01:29Immune Response Against Viral Pathogens
800
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
800
00:42Cross-reactivity
31.2K
Overview
31.2K
01:39Receptor-mediated Endocytosis
104.6K
Overview
104.6K